NCT07715552

Brief Summary

In this study, it was intended to investigate the effect of nano Chitosan (antimicrobial agent) coating on clear aligner orthodontic appliance if it reduces the incidence of white spot lesions (demineralization) of enamel surfaces.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Oct 2025Oct 2026

Study Start

First participant enrolled

October 12, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 7, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 20, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 29, 2026

Expected
Last Updated

July 20, 2026

Status Verified

July 1, 2026

Enrollment Period

9 months

First QC Date

July 7, 2026

Last Update Submit

July 16, 2026

Conditions

Keywords

Chitosan nanoparticles, White spot lesions, Demineralization, QLFChitosan nanoparticlesWhite spot lesionsEnamel DemineralizationQuantitative Light-Induced Fluorescence (QLF)

Outcome Measures

Primary Outcomes (2)

  • White spot lesion area

    It measures the area of enamel demineralization in pixels (Using the QLF system)

    3 months

  • Mean of fluorescence loss (Delta F) in percent

    It measures the percentage of fluorescence loss in the white spot lesion compared to that of sound enamel reflecting the amount of mineral loss using the QLF system

    3 months

Study Arms (2)

Intervention

EXPERIMENTAL

Chitosan nanoparticle coating of the clear orthodontic aligners that will be used by the participants

Other: chitosan nanoparticles

Control

PLACEBO COMPARATOR

The clear orthodontic aligners that will be used by the participants are not coated with anything.

Other: No Treatment Added

Interventions

Clear orthodontic aligners will be coated with nanoparticle sized Chitosan to investigate its anti-microbial effect on development of white spot lesions underneath the aligners

Intervention

No coating of the orthodontic aligners

Control

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients presenting with mild to moderate malocclusion (sagittal, vertical, transverse discrepancies, or crowding) that could be treated using clear aligners within a maximum treatment period of one year and without the need for extraction therapy.
  • Medically healthy patients with no systemic diseases or medical conditions that could affect enamel integrity, salivary flow, oral hygiene status, or periodontal health.
  • Patients with no history of previous orthodontic treatment, dental trauma, or parafunctional habits such as bruxism.
  • Patients with good oral hygiene and absence of active periodontal disease, including gingivitis or periodontitis.
  • Patients willing to comply with the prescribed clear aligner wear protocol for a minimum of 22 hours per day.
  • Patients who agreed to participate in the study and signed the informed consent form.

You may not qualify if:

  • Previous orthodontic treatment that could influence baseline enamel condition or white spot lesion assessment.
  • Presence of active carious lesions, cavitated lesions, severe enamel hypoplasia, or developmental enamel defects.
  • Extensive restorations on anterior teeth that could interfere with Quantitative Light-Induced Fluorescence (QLF) imaging and analysis.
  • Systemic diseases or medical conditions affecting salivary flow, enamel integrity, oral hygiene, or periodontal health.
  • Use of medications known to affect salivary secretion, enamel mineralization, or oral microbial balance.
  • Poor oral hygiene or presence of active periodontal disease, including gingivitis or periodontitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Postgraduate Orthodontic Clinics

Irbid, 22110, Jordan

Location

Study Officials

  • Susan Al-Khateeb

    Jordan University of Science and Technology

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2026

First Posted

July 20, 2026

Study Start

October 12, 2025

Primary Completion

June 30, 2026

Study Completion (Estimated)

October 29, 2026

Last Updated

July 20, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

The data will be provided at reasonable request

Locations